Please wait. Loading...
 

Past Issues

Chiesi Ελληνική Πνευμονολογική Εταιρεία - Hellenic Thoracic Society

PNEUMON is a peer reviewed, bilingual (Greek and English), journal published quarterly as the official scientific journal of the Hellenic Thoracic Society and the Hellenic Bronchologic Society. The Journal publishes original papers of international interest on laboratory and clinical research that are pertinent to lung biology and disease. Clinical and experimental work dealing with the whole field of respiratory medicine, including allied health, cell and molecular biology, epidemiology, immunology, pathology, pharmacology, physiology, intensive and critical care, pediatric respiratory medicine and thoracic surgery will be considered for publication.

Articles published in PNEUMON address topics related to pneumonology and critical care medicine in the following categories: (1) Editorials, (2) Reviews, (3) Basic and Clinical Research Studies, (4) Case Reports, (5) Special Articles, and (6) Letters to the Editor. Details on the length and number of references for each type of publication can be found at the end of this text.

Editorials, reviews and special articles are published following invitation by the Editorial Board. The Editorial Board reserves the right of publishing other types of papers as well. Papers submitted for publication will not be returned, irrespective of whether they are published or not. Published papers are a literary property of both the authors and the journal and their publication, in part or in whole, without written permission of the Editorial Board is prohibited.

 

Requirements and Ethics of Publication

Manuscripts containing original material are accepted for consideration if neither the article nor any part of its essential substance has been or will be published or submitted elsewhere. Copies of any closely related manuscripts must be submitted along with the manuscript. PNEUMON discourages the submission of more than one article dealing with related aspects of the same study. Authors are advised to follow the "Uniform Requirements for Manuscripts Submitted to Biomedical Journals," published by the InternationalCommittee of Medical Journal Editors (http://www.icmje.org;accessed November 9, 2008).

 

Credit for Authorship

Following the recommendations of the International Committee of Medical Journal Editors, "author" is a person who has participated sufficiently in the work to take public responsibility for portions of the content. Specifically, an author is a person who (1) has made substantial contributions to conception and design, or acquisition of data, or analysis and interpretation of data; (2) has drafted the submitted article or revised it critically for important intellectual content, and (3) has provided final approval of the version to be published. Any person who does not meet all three of the listed criteria does not qualify as an author and should not be designated as an author. Importantly, any change in authorship after submission must be approved in writing by all authors.

 

Human and Animal Study Guidelines

PNEUMON endorses recommendations concerning human research described in the Declaration of Helsinki (World Medical Association Declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects. JAMA 1997;277:925-926. Available at: http://www.wma.net/e/policy/b3.htm;accessed November 9, 2008). Manuscripts that do not conform to these recommendations may not be considered for publication. Manuscripts reporting human research must state within the text that the study has been approved by the Review Board or Ethics Committee of their Institution and that written informed consent was obtained from all subjects or their surrogates. Additionally, authors must omit form their manuscripts any identifying details regarding patients or study participants. Patient details (e.g. photographs) may be included in a manuscript only if they are essential for scientific purposes and, in that case, authors must provide written informed consent from the patient, parent or guardian, and this must be clearly stated in the manuscript.

Animal studies must follow internationally recognized guidelines, e.g. the US national Research Council guidelines (Institute of Laboratory Animal Resources, National Research Council. Guide for the care anduse of laboratory animals. Washington, DC: National Academy Press, 1996.Available at: http://books.nap.edu/catalog.php?record_id=5140; accessed November 9, 2008). Humane care for all animals isrequired, and details should be provided.

 

Reporting Clinical Trials

PNEUMON requires that investigators register their clinical trials (other than phase 1 trials) in a public trials registry (e.g.http://www.clicaltrials.gov). According to the WHO definition, a clinical trial is "any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes." The name of the registry and the registration number should be clearly stated in the last paragraph of the Abstract and in the Materials and Methods section of the manuscript. Purely observational studies (those in which the assignment of the medical intervention is not the discretion of the investigator) do not require registration. Further information on this subject can be found on the International Committee of Medical Journal Editors website (http://www.icmje.org).

In manuscripts that report data from randomized clinical trials, authors should follow the flow diagram and/or checklist of the Consolidated Standards of Reporting Trials (CONSORT) format and provide all the information required (available at: http://www.consort-statement.org;accessed November 9, 2008).

 

Reporting Other Types of Studies

PNEUMON suggests that authors follow the international standards for other types of publications. For example, (1) meta-analyses and systematic reviews should conform to the QUOROM requirements (Moher D, et al. Lancet 1999; 356: 1996-2000); (2) meta-analyses of observational studies in epidemiology should conform to the MOOSE requirements (Stroup DF, et al. JAMA 2000; 2008-2012); (3) studies of diagnostic accuracy should conform to the STARD statement (available at http://www.stard-statement.org;accessed November 9, 2008); and (4) observational studies in epidemiology should conform to the STROBE statement (von Elm E, et al. BMJ 2007;335;806-808).

 

Conflicts of Interest

A conflict of interest exists if authors or their institutions have financial or personal relationships with other people or organizations that might inappropriately affect, ormight reasonably be thought by others to affect, the authors' judgment oractions. Examples of financial conflicts include employment, consultancies, stock ownership, honoraria, paid expert testimony, patents or patent applications, and travel grants, all within 3 years of beginning the work submitted. Conflicts of interest should be clearly stated in the Title page ofthe manuscript. If there are no conflicts of interest, authors should state that. For further information on how to report conflicts of interest, authors may refer to "the Lancet's policy on conflicts of interest" (James A,Horton R. Lancet 2003; 3618-9).

 

Tobacco Policy

PNEUMON will not consider for publication manuscripts that have been supported in whole or in part or sponsored in any way by tobacco companies and associated institutes and organizations.

 

 

MANUSCRIPT SUBMISSION

All manuscripts and correspondence can be submitted by e-mail to the address pneumon@hts.org.gr. All submissions should include a Cover Letter and a single Manuscript file (including Body ofManuscript, References, Tables, Figure Legends, and Figures). Figures may besubmitted also as separate files. All text should be double-spaced using12-point type face (Arial or Times New Roman) and should be prepared in a word processing format (Microsoft Word preferred; an acceptable alternative would be PDF format). For the suggested length of publications please refer to Table 1 at the end of this document.

All authors must sign an agreement form (agreement form). The form must be scanned and send by e-mail at the time of the submission of the manuscript. 

Cover Letter

All manuscripts should be accompanied by a cover letter, signed by the corresponding author, clearly stating the following:

  1. Neither the article nor any part of its essential substance has been or will be published or submitted elsewhere; if papers closely related to the submitted manuscript have been published or submitted for publication elsewhere, the authors should provide details.
  2. The clinical relevance of the work described and what it adds to the current literature.
  3. Potential significant conflicts of interest.
  4. The manuscript has been prepared according to the instructions for authors of PNEUMON and all authors have read and approved the text of the article.
  5. If accepted for publication, the copyright will be transferred to PNEUMON Journal.

Failure to provide a cover letter addressing each ofthe points above will result in the paper being returned to the author. The cover letter must be presented as a separate submission item.

 

Title page

The title page must contain the following information:

  1. The title of the manuscript (no more than 10 words). If it is necessary the title can include a sub-title
  2. The full name, institutions, city and country for all co-authors
  3. The full name, postal address, e-mail, telephone, and fax numbers of the corresponding author.
  4. Conflicts of interest of all authors.
  5. Potential funding or grant support of the work described.
  6. A running (short) title.
  7. The total number of words of the manuscript and the abstract.

 

Abstract

A structured abstract should be provided of up to 250words. It should consist of four paragraphs, labeled Background, Methods, Results, and Conclusions. They should briefly describe, respectively, the problem being addressed in the study, how the study was performed, the most important results, and what the authors conclude from the results. Abbreviations should be avoided and, if used, they should be explained the first time mentioned.

 

Keywords

Up to 5 keywords that reflect the content of the manuscript should be provided. Authors should consult the Medical Subject Headings (MeSH) website (available at http://www.nlm.nih.gov/mesh/meshhome.html;accessed on November 9, 2008).

 

Abbreviations

Please provide an alphabetical list of all abbreviations used in the manuscript on a separate page. For clarity reasons, please use abbreviations sparingly. When abbreviations are used, they should be explained the first time they are mentioned in the text.

 

Body of Manuscript

The paper should include the following sections:

Introduction

The rationale for the study should be summarized and relevant background material outlined. The Introduction should not contain findings, methods used or conclusions.

Methods

Methods should be described in adequate detail to assure the reader as to how the results were obtained. In manuscripts reporting human research, the authors should report approval by the Review Board or Ethics Committee and that written informed consent was obtained from patients. The location (city, state, country) of a manufacturer listed in the text should be provided. Units should conform to SI conventions. Generic names of drugs should be used instead of trade names. Statistical methods should be meticulously described and referenced.

Results

Results should be presented in a rational order in the text, tables and figures. The authors should avoid repetitive presentation of the same data in different forms, especially between the text and tables and figures. The Results should not include material appropriate to the Discussion.

Discussion

The discussion should start by presenting the new and most interesting data of the work in relation to any hypotheses made in the Introduction. Any unexpected or contradictory results should be explained or defended. For example, evaluation of methodology and the associations of new information to the existing knowledge in the topic should be discussed. Speculation should be kept to a minimum. The results must not be simply reiterated. New results should not appear in the Discussion. No specific reference to figures and tables should be included in the Discussion.

Acknowledgements

Acknowledge the persons who provided a true contribution and who endorse the data and conclusions. Acknowledge any funding sources.

References

Only published works may be cited as references. Manuscripts accepted but not yet published may be cited designating the accepting journal, followed by the term (in press), and copies of the in-press articles should be provided for reviewer inspection. References should be cited in the manuscript with superscript numerals in the order in which they appear in the text. The full list of references should be provided in numerical order on a separate page at the end of the text. References should include, in order, the following: authors, title, source, year of publication, volume, and inclusive page numbers. All authors should be listed if they are six or fewer; when they are seven or more, list the first three followed by "et al." Please abbreviate journal names as in Index Medicus (available athttp://www.nlm.nih.gov/tsd/serials/lji.html;accessed on November 9, 2008).

The following are sample references:

  • Standard journal article: Bouros D, Antoniou KM, Light RW. Intrapleural streptokinase for pleural infection. BMJ 2006; 332:133-4.
  • Books and other monographs: Siafakas NM, Anthonisen N, Georgopoulos D. Acute exacerbations of COPD. Marcel Dekker, New York, 2004.
  • Chapter in a book: Kyriakou D, Alexandrakis M, Bouros D. Pleural effusions in blood diseases. In: Bouros D. (editor). Pleural Disease. Marcel Dekker, New York, 2004, pp. 621-638.

Numbered references to personal communications, unpublished data, or manuscripts either "in preparation" or "submitted for publication" are unacceptable. If essential, such material can be incorporated at the appropriate place in the text.

 

Tables

Double-space tables (including any footnotes) should be presented on separate pages, providing a title for each. Any abbreviations used in a Table should be defined in the Table's footnote.

 

Figures

Figures may be inserted in the text file or in a separate file (accepted formats are JPEG, TIFF and EPS). Legends for all figures should be included in the file with the text, on a separate page after the Tables, and should not appear on the actual figures. If photographs of patients are used, they should either not be identifiable or the photographs should be accompanied by written permission to use them.

 

Permission

The manuscript must be accompanied by copies of permission to reproduce previously published material (figures or tables); touse illustrations of, or report sensitive personal information about, identifiable persons; and to name persons in the Acknowledgments section.

 

SUBMISSION:

Editor-in-Chief:

Professor Demosthenes Bouros,  MD, FCCP

PNEUMON Journal, Hospital for Diseases of the Chest

"SOTIRIA", 152 Messogeion Ave, 11527, Athens, GREECE

Tel/Fax: +30-210-7487723

http://www.pneumon.orghttp://www.hts.org.gr

e-mail: pneumon@hts.org.gr

 

Table1

Suggested Maximum Length Requirements for Submitted Manuscripts

(November 2008)

 

 

Type of publication

 

Abstract

(words)

Body of

Manuscript

(words)*

 

References

(number)

Editorial

n/a

1000

15

Original Research

250

3500

50

Reviews

250

4500

100

Case Reports

150

1500

20

Special Articles

250

2500

50

Correspondence

n/a

500

5

*excluding References, Tables, Acknowledgements andFigure Legends

n/a: not applicable

Manuscript Submission

You can submit your manuscript using the following form

  •  
  •  
  •  
  • Please include all the files into one zip file.
     
  •  
© 2011 PNEUMON Magazine, Hellenic Bronchologic Society.
Developed by LogicONE Logo LogicONE